Uncommon biphasic CAR-T expansion induces hemophagocytic lymphohistiocytosis-like syndrome and fatal multiple infections following BCMA CAR-T cell therapy: a case report
Journal for ImmunoTherapy of Cancer · 2024
DOI: 10.1136/jitc-2024-010080 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal for ImmunoTherapy of Cancer, 2024. Verfasst von Wenqiang Yan und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute …. Hauptthemen laut MEDLINE: B-Cell Maturation Antigen, Immunotherapy, Adoptive, Lymphohistiocytosis, Hemophagocytic, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Chinese Academy of Medical Sciences Initiative for Innovative Medicine, National Natural Science Foundation of China.
Abstract (Originalsprache)
B-cell maturation antigen(BCMA)-directed chimeric antigen receptor (CAR)-T-cell therapy has significantly improved the treatment of relapsed or refractory multiple myeloma (MM). Nevertheless, the uncommon phenomenon of biphasic CAR-T cell expansion in vivo and its related severe toxicities have not been methodically described and studied. Herein, we report a case of patients with MM who experienced two CAR-T cell expansion peaks and subsequently developed multiple severe toxicities following BCMA CAR-T cell infusion. The first expansion peak occurred on Day 7, accompanied by grade 3 cytokine release syndrome. The second peak occurred on Day 28, associated with severe immune effector cell-associated hematotoxicity (ICAHT), immune effector-cell associated hemophagocytic lymphohistiocytosis-like syndrome (IEC-HS), and polymicrobial infections. Both ICAHT and IEC-HS were refractory to our standard treatments; however, human umbilical cord mesenchymal stem cell infusion exhibited some efficacy in improving cytopenia. Despite the administration of a broad-spectrum anti-infective regimen, cytomegalovirus viremia remained uncontrollable, resulting in the development of central nervous system infection, neurological symptoms, and ultimately death. Additionally, we also employed high-dimensional 33-color spectral flow cytometry to describe the dynamic changes in immune cell components and functions between the two expansion peaks. Collectively, this case provides novel insights into the biphasic CAR-T expansion and related immune effector cell-associated toxicities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sc…
- Tianjin Institutes of Health Science, Tianjin, China.
- Department of Radiation and Medical Oncology for Esophageal Mediastinal and Lymphatic tumors, Zhongnan Hospital of Wuhan University, Wuhan, China.
- Beijing GoBroad Boren Hospital, Beijing, China.
ORCID-Profile: Wenqiang Yan, Dehui Zou
Förderung
- Chinese Academy of Medical Sciences Initiative for Innovative Medicine
- National Natural Science Foundation of China
Zitieren
APA
Yan, W., Xiong, Y., Lv, R., Du, C., Yu, T., Zhang, S., Sui, W., Deng, S., Xiao, J., Xu, Y., Zou, D., Qiu, L., & An, G. (2024). Uncommon biphasic CAR-T expansion induces hemophagocytic lymphohistiocytosis-like syndrome and fatal multiple infections following BCMA CAR-T cell therapy: a case report. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2024-010080
Vancouver
Yan W, Xiong Y, Lv R, Du C, Yu T, Zhang S, et al. Uncommon biphasic CAR-T expansion induces hemophagocytic lymphohistiocytosis-like syndrome and fatal multiple infections following BCMA CAR-T cell therapy: a case report. Journal for ImmunoTherapy of Cancer. 2024. doi:10.1136/jitc-2024-010080
BibTeX
@article{Yan2024,
author = {Yan, Wenqiang and Xiong, Yu and Lv, Rui and Du, Chenxing and Yu, Tengteng and Zhang, Shuaishuai and Sui, Weiwei and Deng, Shuhui and Xiao, Jigang and Xu, Yan and Zou, Dehui and Qiu, Lugui and An, Gang},
title = {Uncommon biphasic CAR-T expansion induces hemophagocytic lymphohistiocytosis-like syndrome and fatal multiple infections following BCMA CAR-T cell therapy: a case report},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2024},
doi = {10.1136/jitc-2024-010080}
}
EUVIMED